ℹ️
🇬🇧
Search
Search for publications relevant for "infusion reaction"
infusion reaction
Publication
Class
Person
Publication
Programmes
publication
Management of severe infusion reactions after cetuximab
2008 |
First Faculty of Medicine
publication
Successful management of infusion reaction accompanying the start of cetuximab therapy
2007 |
Publication without faculty affiliation
publication
Successful management of infusion reaction accompanying the start of cetuximab therapy
2007 |
First Faculty of Medicine
publication
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
2017 |
First Faculty of Medicine
publication
Management of severe infusion reactions after cetuximab
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Successful management of infusion reaction accompanying the start of cetuximab therapy
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Ofatumumab
2011 |
Faculty of Medicine in Hradec Králové
publication
Is there a real difference in the safety of infliximab treatment alone and infliximab combined with concomitant immunosuppression? Single centre experience
Publication without faculty affiliation
publication
Isatuximab for the treatment of relapsed/refractory multiple myeloma
2020 |
First Faculty of Medicine
publication
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients
2015 |
Publication without faculty affiliation
publication
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients
2015 |
Faculty of Medicine in Hradec Králové
publication
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
2012 |
Second Faculty of Medicine
publication
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
2015 |
First Faculty of Medicine
publication
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
2010 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
2019 |
First Faculty of Medicine